The Clinical Utility of the NETest in Patients with Small Intestinal Neuroendocrine Neoplasms (Si-NENs): A "Real-Life" Study.
NETest
biomarker
prognosis
small intestinal neuroendocrine neoplasms
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
10 Jul 2024
10 Jul 2024
Historique:
received:
10
06
2024
revised:
24
06
2024
accepted:
27
06
2024
medline:
27
7
2024
pubmed:
27
7
2024
entrez:
27
7
2024
Statut:
epublish
Résumé
Current biomarkers do not adequately predict the behaviour of neuroendocrine neoplasms (NENs). This study assessed the NETest, a multianalyte blood biomarker, in patients with small intestinal NENs (Si-NENs). We studied two patient groups: Group 1: metastatic Si-NENs (
Identifiants
pubmed: 39061146
pii: cancers16142506
doi: 10.3390/cancers16142506
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : WREN laboratories (Europe)
ID : Educational Grant